 |
Invivotek |
 | Invivotek社は、Genesis Drug Discovery & Development company (GD3)のメンバーで、癌をはじめ、免疫疾患/炎症や代謝疾患等のin vivoモデルを用いて、新薬候補物質の評価を行います。
《サービス一覧》
◆ Oncology & Immuno-Oncology |
|
Xenograft (CDX) and Syngeneic Tumor models を用いたEfficacy study (実験例)
モデルのタイプ Orthotopic Metastatic Disseminated Subcutaneous |
投薬方法 Oral Gavage Bolus Injections: subcutaneous, Intra-tumoral, Intra-peritoneal, Intravenous, Intra-cardiac, Intramuscular, Intra-articular, Intra-dermal, Intra-ttracheal Osmotic Mini-pumps In-Diet Administration
|
Imagingによる腫瘍(自然転移・実験的転移等)の観察同所性及び転移癌の増殖を、in vivoでリアルタイムに観察できます。(実験例) FACS及びマルチプレックス解析 血液や各種器官の組織からsingle cell suspensionsを作製し、FACS解析を実施。 腫瘍浸潤リンパ球(Tumor-infiltrating lymphocytes)の同定や、サイトカイン及びホルモン等のマルチプレックス解析の経験も豊富です。
RadiotherapySmall Animal Radiation Research Platform (SARRP)を用いた放射線治療も可能です。放射線治療と投薬治療を組み合わせた実験も対応します。(実験例)
CDX及びSyngeneicモデルの詳細につきましては、お問合せください。 |
◆ Immunology & Inflammation |
|
免疫及び炎症に焦点を当てた幅広い疾患モデルを用いて、各種アッセイが可能です。 Animal Disease Models (免疫/炎症疾患)
Antigen-induced Rheumatoid Arthritis
Collagen-induced Rheumatoid Arthritis
Monoclonal antibody induced Rheumatoid Arthritis
Experimental Autoimmune Encephalitis (AEA)for Multiple Sclerosis (MS)
Allergen-induced pulmonary inflammation for asthma
Lipopolysaccharide (LPS)-induced airway inflammation
Acute lung injury model (LPS-induced)
Dextran Sulfate Sodium (DSS)-induced colitis for ulcerative colitis
Trinitrobenzene sulfonic acid (TNBS)- induced colitis for Crohn’s disease
Allergic Dermatitis [fluorescein isothicyanate (FITC), dinitrofluorobenzene (DNFB) or Oxazolone-induced]
Antigen-induced Myasthenia gravis
Graft vs. Host Disease
Ex Vivo Bioassays
Serum and tissue cytokine profiling in animal disease models
FACS analysis of lymphoid organs and tissue infiltrates
Hematology five-part differential cell count
Proliferative responses of T and B cells in vitro
In vitro cytokine production assays
T cell differentiation assay
◎ FACSパネル (Multi-Color Panels for FACS Staining)
・ Treg Panel | ・ Inflammatory Infiltrate Panels |
・ MDSC Panel | ・ M1/M2 Monocyte/ Macrophage Panel |
・ Lymphocyte Panel | ・ White Blood Cell Profiling Panel (T and B cells, monocytes, NK cells) |
◎ 検証済み組織等 (Validated protocols are developed)
・ Blood | ・ Brain and spinal cord |
・ Spleen | ・ Liver |
・ Bone Marrow | ・ Adipose Tissue |
・ Lymph Nodes | ・ Intestine |
・ Tumor | ・ Skin |
Cell Therapy Evaluation セルベースの治療アッセイにも豊富な経験があります。
Pluripotent Stem cell therapies for multiple indications in:
・ Oncology
・ Neuroinflammation
・ Autoimmune disorders
CAR-T cells (Chimeric Antigen Receptor modified T cells)
Non-Disease In Vivo Bioassays
Non-lethal endotoxemia with LPS
Antigen-dependent in vivo T cell proliferation by BrdU uptake
OVA-stimulated in vivo antibody production (IgG1, IgG2a, IgG2b)
KLH-stimulated in vivo antibody production (IgM, IgG)
Delayed-type hypersensitivity induced by methylated bovine serum albumin (mBSA) or Keyhole limpet hemocyanin (KLH) with adjuvant
Delayed-type hypersensitivity induced by SRBC
Monocyte or neutrophil infiltration induced by thioglycollate, zymosan, curdlan, or trypsin
Cutaneous wound healing
|
◆ Metabolic Disease Models |
|
正常なマウスの他、非アルコール性脂肪性肝炎(NASH)や非アルコール性脂肪肝(NAFL)等の疾患モデルを用いた各種アッセイが可能です。
Animal Disease Models (代謝疾患)
Diet-Induced obesity
Streptozotocin (STZ)-induced diabetes
Genetic models of diabetes and obesity
Nonalcoholic steatohepatitis
・ Choline-deficient, amino acid defined High Fat Diet (CDA-HFD)
・ Neonatal streptozotocin HFD model
・ High fat (palm oil), high cholesterol, high fructose obesity model
Genetic models of atherosclerosis and dislipidemia
In vivo Energy Homeostasis and Body Composition Assessment
Longitudinal body weight gain
Body composition by DEXA:
・ Fat mass/ % fat/ lean mass/ % lean/ total tissue mass/ tissue area
・ Bone mineral density and content/ bone area
Assessment of regional adipose depots
Food intake
Indirect calorimetry and locomotor activity:
・ O2 consumption/ CO2 production/ respiratory exchange ratio (RER)
・ Total horizontal / ambulatory/ non-ambulatory/ vertical activity
Glucose Homeostasis
Glucose and insulin levels in glucose tolerance tests
Gastric emptying
Insulin tolerance test
Tissue glycogen levels
Pancreatic insulin content
Glucagon, adiponectin, GLP-1and other circulating hormones
Lipid Metabolism
Triglyceride levels in oral lipid tolerance tests
De novo lipogenesis in vivo
Hepatic triglyceride export
Serum leptin levels
Serum ketone levels
Serum and hepatic triglyceride levels
Serum free fatty acids
Serum and hepatic cholesterol levels
Cholesterol distribution: VLDL, LDL, HDL
Serum corticosterone levels
Cardiovascular Function
Non-invasive blood pressure & heart rate with and without L-NMMA Challenge
Exercise capacity
Histological assessment of atherosclerosis
Arteriogenesis
Hind-limb ischemia (実験例)
・ Includes laser Doppler measured cutaneous blood flow
・ Functional clinical score
・ Immunohistochemical analysis
|
◆ Neuroscience |
|
行動、痛み、運動機能等の様々なアッセイにより、神経疾患に対する候補物質の有効性や毒性を評価します。
Neurology
・ Locomotor activity (open field, long-term locomotor activity in home cage)
・ Rotorod
・ Grip strength
・ Behavioral Battery
Pain
・ Acute nociception - Hot plate - Acetic acid - Tail flick - Hargreaves
・ Chronic pain models - Inflammatory neuritis-carrageenan induced sciatic nerve in rats - Inflammatory pain–carrageenan and complete Freund’s adjuvant foot pad injection
Opioid withdrawal model
Affective Disorders
・ Elevated Plus maze
・ Open field
・ Novel environment induced feeding suppression
|
|
|
※掲載されている製品及び受託サービスは全て研究用です。目的を問わず人体への投与を含む、医薬品、診断用医薬品、食品、食品用検査、化粧品等の用途には使用できません。研究用以外の目的には使用しないでください。 |